Evidence map›Paper›PMID 29478100›Full record

ArticleCancer immunology, immunotherapy : CII2018

Certain BCG-reactive responses are associated with bladder cancer prognosis.

Guang Shan, Tian Tang, Huijun Qian, Yue Xia

Open access · greenAbstract read
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Exploiting Pre-Existing CD4Journal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Guang ShanDepartments of Urology II, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, Hubei, China. guangshandoc@sina.com.ORCID 0000-0001-5133-5634
Tian TangDepartments of Oncology II, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Huijun QianDepartments of Urology II, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, Hubei, China.
Yue XiaDepartments of Urology II, Renmin Hospital of Wuhan University, 238 Jiefang Road, Wuhan, Hubei, China.
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A subset of bladder patients does not respond to BCG treatment effectively and the underlying reason behind this observation is currently unclear. CD4

Indexed as

BCG VaccineCD8-Positive T-LymphocytesCells, CulturedHumansInterferon-gammaInterleukin-21InterleukinsMacrophagesPrognosisUrinary Bladder NeoplasmsBCG VaccineInterferon-gammaInterleukin-21InterleukinsBCGBladder cancerPrognosisT cell

Identifiers

PMID29478100
PMCPMC11028363
OpenAlexW2791638157

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.